[Retracted] Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature

Figure 6

Clinical relevance and survival analyses in the GEO combined cohort. (a) Correlations between NAGs and OS. (b) Comparisons of clinicopathological feature distributions between the high and low NAGs groups. (c). Discriminative accuracy validation in GEO combined cohort; ROC analysis was conducted to calculate the AUC value at 1 year, 3 years, and 5 year, respectively. (d). High and low NAGs patients in GEO combined cohort. (e) Comparisons of OS between patients with high NAGs and low NAGs, the results were depicted via K-M curves. (f) Multivariate Cox regression analysis.

(a)

(b)

(c)

(d)

(e)

(f)

(g)